Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3784154

Cc1nc(NCCN2CCN(C(=O)OC(C)(C)C)CC2)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 9/20 0.42
PIK3CA P42336 9/20 0.42
PIK3CB P42338 9/20 0.42
MTOR P42345 9/20 0.42
PIK3CG P48736 9/20 0.42
BRAF P15056 1/20 0.38
INSR P06213 3/20 0.38
LCK P06239 3/20 0.38
LYN P07948 3/20 0.38
HCK P08631 3/20 0.38
SRC P12931 3/20 0.38
KDR P35968 3/20 0.38
ACHE P22303 1/20 0.37
ACKR3 P25106 4/20 0.36
CCR5 P51681 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OGFRL1 Q5TC84 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL9948407 0.89 PIK3CD (0.43) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL9949096 0.81 MTOR (0.49) PIK3CDPIK3CAPIK3CBMTORPIK3CG
Trifluoroacetic Acid SCHEMBL3782649 0.81 MTOR (0.44) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3785561 0.81 ACKR3 (0.43) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3785668 0.81 PIK3CD (0.48) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3784964 0.77 MTOR (0.54) PIK3CDPIK3CAPIK3CBMTORPIK3CG
Hydrochloric Acid SCHEMBL3790661 0.76 MTOR (0.53) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3715483 0.75 MTOR (0.53) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL9948606 0.74 MTOR (0.53) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3717022 0.74 MTOR (0.54) PIK3CDPIK3CAPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165334-A1 Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors AMGEN INC. (US) 2012-06-28 US disclosed
EP-2398791-A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS Amgen, Inc (US) 2011-12-28 EP disclosed
WO-2010096314-A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS AMGEN INC. (US) 2010-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165334-A1 Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors MTOR, PIKFYVE, RICTOR PIK3CD 8/4885PIK3CA 9/4885PIK3CB 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.